FreightCar America RAIL 深 沪
交易中 09-16 15:36:13 美东时间
10.2281
-0.102
-0.99%
华盛通- 最 高10.73
- 今 开10.50
- 成交量 45.88万股
- 最 低 9.22
- 昨 收 10.33
- 总市值 1.83亿
- 52周最高 10.73
- 市盈率 静 --
- 换手率 2.56%
- 52周最低 2.25
- 委 比 -30.00%
- 总股本 1790.34万
- 历史最高 36.43
- 量 比 1.12
- 振 幅 14.62%
- 历史最低 0.73
- 每 手 1
- 风险率 1.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Illumina wins legal battle over Grail deal in EU; avoids €432M fine
A top court in the EU on Tuesday ruled against the European Commission's decision to review Illumina's (NASDAQ:ILMN) 2021 acquisition of cancer test developer Grail (NASDAQ:GRAL), eliminating the €432...
09-03 19:10
Illumina Hails ECJ Ruling, Eliminates €432M Fine Over GRAIL Acquisition
Illumina, Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, welcomes the European Court of Justice's (ECJ's) judgment today ruling that the European Commission did not have jurisdiction
09-03 16:05
12 Industrials Stocks Moving In Monday's After-Market Session
Gainers Safe Pro Group (NASDAQ:SPAI) shares rose 15517.9% to $663.76 during Mo...
09-03 04:31
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)
MENLO PARK, Calif., Aug. 30, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a...
08-31 05:55
FDA approves Illumina's TruSight Oncology biomarker test
The FDA has approved Illumina’s (NASDAQ:ILMN) TruSight Oncology Comprehensive biomarker test and two companion diagnostic indications. TruSight was approved as a companion diagnostic to identify adult...
08-28 05:12
“滴血验癌”梦想照进现实，觅瑞领跑胃癌早筛全球最大市场
本报（chinatimes.net.cn）记者于娜 北京报道 资本寒冬下，无论是投资机构还是上市药企都寻求确定性的赛道布局，癌症早筛等慢性病防治领域成为目标之一...
08-26 15:05
Railtown AI Showcases Growth and Financial Health
Railtown AI Technologies Inc (TSE:RAIL) has released an update. Railtown AI Tec...
08-23 10:07
Further Upside For FreightCar America, Inc. (NASDAQ:RAIL) Shares Could Introduce Price Risks After 31% Bounce
FreightCar America, Inc. (NASDAQ:RAIL) shares have had a really impressive mont...
08-14 19:33
GRAIL to focus on multi-cancer early detection; cuts workforce by 30%
After Tuesday's closing bell, GRAIL (NASDAQ:GRAL) said it would focus its resources going forward on its core multi-cancer early detection programs, resulting in a 30% reduction in headcount. In addit...
08-14 05:19
GRAIL shares are trading higher. The company Q2 financial results.
GRAIL shares are trading higher. The company Q2 financial results.
08-14 04:55
